Prescribing fortified eye drops

被引:8
作者
Chiquet, C. [1 ]
Romanet, J.-P. [1 ]
机构
[1] Univ Grenoble 1, CHU Grenoble, Serv Ophtalmol, Grenoble, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2007年 / 30卷 / 04期
关键词
fortified drops; keratitis; endophthalmitis;
D O I
10.1016/S0181-5512(07)89618-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Fortified preparations of ophthalmic antibiotics are made with commercially available antibiotics (parenteral or lyophilized preparations). These fortified eyedrops have two main advantages: the increase in the antibiotic concentration in the corneal stroma and the wide choice of available antibiotics. Fortified ophthalmic solutions are used in severe keratitis (large diameter, stroma infiltration, inflammation of the anterior chamber, old patient). The following associations are recommended: ticarcillin+gentamicin+vancomycin or cephazolin+amikacin since they provide a broad-spectrum antibiotic activity against the wide range of bacteria that may cause keratitis. The main toxicity of these preparations is the retardation effect of the epithelial-healing rate (aminoglycosides, vancomycin) and the corneal and conjunctival toxic effects (aminoglycosides). However, fortified antibiotic drops remain the,standard therapy for severe bacterial keratitis, given their corneal penetration and the possibility of the synergic and combined effect of an antibiotic association.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 48 条
[1]   Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones [J].
Alexandrakis, G ;
Alfonso, EC ;
Miller, D .
OPHTHALMOLOGY, 2000, 107 (08) :1497-1502
[2]   STRATEGIES FOR THE MANAGEMENT OF MICROBIAL KERATITIS [J].
ALLAN, BDS ;
DART, JKG .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (08) :777-786
[3]  
BENSON H, 1974, ARCH OPHTHALMOL-CHIC, V91, P313
[4]  
Bourcier T, 2004, INFECT CORNEENNES DI
[5]   AN INVITRO STUDY OF THE POTENCY AND STABILITY OF FORTIFIED OPHTHALMIC ANTIBIOTIC PREPARATIONS [J].
BOWE, BE ;
SNYDER, JW ;
EIFERMAN, RA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1991, 111 (06) :686-689
[6]  
Bron A, 1999, J FR OPHTALMOL, V22, P1076
[7]  
CALLEGAN MC, 1994, INVEST OPHTH VIS SCI, V35, P1033
[8]   Storage of extemporaneously prepared ophthalmic antimicrobial solutions [J].
Charlton, JF ;
Dalla, KP ;
Kniska, A .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (05) :463-466
[9]  
DAVIS SD, 1977, ARCH OPHTHALMOL-CHIC, V95, P1638
[10]   TOPICAL TOBRAMYCIN THERAPY OF EXPERIMENTAL PSEUDOMONAS KERATITIS - EVALUATION OF SOME FACTORS THAT POTENTIALLY ENHANCE EFFICACY [J].
DAVIS, SD ;
SARFF, LD ;
HYNDIUK, RA .
ARCHIVES OF OPHTHALMOLOGY, 1978, 96 (01) :123-125